Confirmation of-174G/C interleukin-6 gene promoter polymorphism as a genetic marker predicting antitumor necrosis factor treatment outcome

Davila-Fajardo, C.L.; Marquez, A.; Pascual-Salcedo, D.; Ramos, M.J.M.; Garcia-Portales, R.; Magro, C.; ... ; Martin, J. (2014)

Article / Letter to editor

• antitumor necrosis factor
• interleukin-6
• pharmacogenetics
• rheumatoid arthritis
• single-nucleotide polymorphism

• All authors: Davila-Fajardo, C.L.; Marquez, A.; Pascual-Salcedo, D.; Ramos, M.J.M.; Garcia-Portales, R.; Magro, C.; Alegre-Sancho, J.J.; Balsa, A.; Cabeza-Barrera, J.; Raya, E.; Martin, J.
• Date: 2014-01-31
• Journal: Pharmacogenetics and Genomics
• Volume: 24
• Issue: 1
• Pages: 1 - 5
• DOI: doi:10.1097/FPC.0000000000000013